The biochips market is projected to expand from USD 14.01 billion in 2025 to USD 21.36 billion by 2030, driven by a CAGR of 8 ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

The RNA analysis market is poised for significant growth due to rising demand in precision medicine, advancements in NGS technologies, and expanding use of RNA biomarkers in diagnostics and drug ...

The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Abstract: Collagen remodelling plays a critical role in the progression of pancreatic intraepithelial neoplasia (PanIN) to pancreatic ductal adenocarcinoma (PDAC), though misdiagnosis often occurs due ...

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

This article is based on a poster originally authored by Ebru Aydin Kurtulmus, Dagmar Hildebrand, Fiordiligie Casilag, Verena Banschbach, Jessica Heckmann, Sarah Schott, Marc Botcherby and Volker ...

According to Precedence Research, the global microarray market size was estimated at USD 5.46 billion in 2023 and is projected to reach USD 13.81 billion by 2034, registering a CAGR of 8.8% from 2024 ...

ABSTRACT: Objective: The mortality and morbidity rates associated with pancreatic cancer (PaCa) are extremely high. Various studies have demonstrated that pancreatic cancer will be the fourth ...